Inactivation of tumor‐specific CD8+ CTLs by tumor‐infiltrating tolerogenic dendritic cells
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Cancer immunosurveillance failure is largely attributed to the insufficient activation of tumor‐specific class I major histocompatibility complex (MHC) molecule (MHC‐I)‐restricted CD8+ cytotoxic T lymphocytes (CTLs). DEC‐205+ dendritic cells (DCs), having the ability to cross‐present, can present captured tumor antigens on MHC‐I alongside costimulatory molecules, inducing the priming and activation of tumor‐specific CD8+ CTLs. It has been suggested that reduced levels of costimulatory molecules on DCs may be a cause of impaired CTL induction and that some tumors may induce the downregulation of costimulatory molecules on tolerogenic DCs. To examine such possibilities, we established two distinct types of murine hepatoma cell lines, named Hepa1‐6‐1 and Hepa1‐6‐2 (derived from Hepa1‐6 cells), and confirmed that they display similar antigenicities, as well as identical surface expression of MHC‐I. We found that Hepa1‐6‐1 had the ability to grow continuously after subcutaneous implantation into syngeneic C57BL/6 mice and did not prime CD8+ CTLs. In contrast, Hepa1‐6‐2 cells, which display reduced levels of adhesion molecules, such as Intercellular Adhesion Molecule 1 (ICAM‐1), failed to grow in vivo and efficiently primed CTLs. Moreover, Hepa1‐6‐1‐derived factors, such as transforming growth factor (TGF)‐β1, vascular endothelial growth factor (VEGF) and α‐fetoprotein (AFP), converted CD11c high MHC‐II high DEC‐205+ DC subsets into tolerogenic cells, displaying downregulated costimulatory molecules and having impaired cross‐presenting capacities. These immunosuppressive tolerogenic DCs appeared to inhibit the induction of tumor‐specific CD8+ CTLs and suppress their cytotoxic functions within the tumor. Together, the findings presented here provide a new method of cancer immunotherapy using the selective suppression, depletion or alteration of immunosuppressive tolerogenic DCs within tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Cited by
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Tran Janco, J. M., Lamichhane, P., Karyampudi, L., & Knutson, K. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403134 · Cited by 440
Veglia, F., Tyurin, V. A., Mohammadyani, D., Blasi, M., Duperret, E. K., Donthireddy, L., Hashimoto, A., Kapralov, A., Amoscato, A., Angelini, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02186-9 · Cited by 308
Li, J. J., Tsang, J. Y., & Tse, G. M. (2021) · Cancers · doi:10.3390/cancers13164233 · Cited by 180
Natural and Induced Tolerogenic Dendritic Cells
Iberg, C. A., & Hawiger, D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901121 · Cited by 159
Nakagawa, Y., Negishi, Y., Shimizu, M., Takahashi, M., Ichikawa, M., & Takahashi, H. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.07.003 · Cited by 149
Self-citation
Metadata
- Authors
- Harimoto, H., Shimizu, M., Nakagawa, Y., Nakatsuka, K., Wakabayashi, A., Sakamoto, C., & Takahashi, H.
- Venue
- Immunology & Cell Biology
- Publisher
- Wiley
- Published
- 2013-09-10
- Volume
- 91
- Issue
- 9
- Pages
- 545-555
- ISSN
- 0004-945X (ISSN-L)
- 0818-9641
- 1440-1711
- OpenAlex
- W1994024849
- Cited by
- 99
- References
- 1
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.